Tvp22 01 omslag kijk verder

Keywords register: schizophrenia

Short report

50th anniversary issue 2008, suppl.2

D. Denys, L. de Haan

25 years antipsychotics: back to the future?, 105 - 109



E. Thys, C.I. Struyven, M. De Hert

The stigmatisation of schizophrenia, psychosis and autism in the Flemish daily papers, 1030 - 1039



J. Deenik, D.E. Tenback, E.C.P.M. Tak, I.J.M. Hendriksen, P.N. van Harten

Thinking inside the box: improving the lifestyle of inpatients with severe mental illness, 564 - 574



K. Plasmans, I. Glazemakers, G. Dom

Perinatal mental health care for mothers with schizophrenia in Flanders; where are we still short?, 626 - 634

Klinische Praktijk


L. Castelein, J. Steyaert, H. Peeters, G. van Buggenhout

Adolescent with a schizophreniform disorder and recurrent 16p11.2 duplication, 421 - 425

Review article


S.K. Spoelstra, L. Visser, H. Knegtering

Cariprazine for acute and maintenance treatment of schizophrenia, 702 - 709



M. Molag, T. Beckers, H.J.E. van de Mortel

The implementation of the multidisciplinary guidelines for treatment of schizophrenia in teams for flexible assertive community treatment: a retrospective study of patient files, 521 - 526

Short report

2018/3 themanummer Personalised Medicine

W. Veling, I.E.C. Sommer, R. Bruggeman, L. de Haan

Personalised medicine for psychosis, 161 - 165

Review article


S.K. Spoelstra, L. Bais, H. Knegtering

The three-monthly paliperidone palmitate depot in the treatment of schizophrenia, 827 - 833

Short report


D.P. Muller, L. de Haan

Smoking cessation and schizophrenia, 297 - 301

Short report


H.G. van Dijk*, E.A. Dapper*, C.H. Vinkers

SSRIs and depressive symptoms in schizophrenia: a systematic review, 40 - 46

Review article


T. Sabbe, J. Detraux, M. De Hert

Prolactin, antipsychotics and breast cancer: is there a connection?, 641 - 649



P.F. Bouvy

Schizophrenia exists: yes / no / don’t know, 513 - 519

Short report


D. Muller, F. Schirmbeck, L. de Haan

Recommendations regarding diagnosis and treatment of obsessive-compulsive symptoms in schizophrenia, 529 - 534

Review article


S. de Jong, R.J.M. van Donkersgoed, J. Arends, P.H. Lysaker, L. Wunderink, M. van der Gaag, A. Aleman, G.H.M. Pijnenborg

Metacognition in psychotic disorders: from concepts to intervention, 455 - 462

Case report


TH. van Oeffelt, E.J.D. Prinsen

Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review, 309 - 313

Review article


O. de Wachter, J. De La Asuncion, B. Sabbe, M. Morrens

Social dysfunction in schizotypy, 114 - 121

Review article


C.P. Engelhard, G. Touquet, A. Tansens, J. De Fruyt

Alcohol-induced psychotic disorder: a systematic literature review, 192 - 201

Review article


P. Martinez-Martinez*, P.C. Molenaar*, M. Losen, C. Hoffmann, J. Stevens, L.D. de Witte, T. van Amelsvoort, J. van Os, B.P.F. Rutten

Auto-immune disorders as a possible cause of neuropsychiatric syndromes, 183 - 191

Short report


C.H. Vinkers, I.E. Sommer

Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands, 830 - 834

Review article


J.D. Blom

The delusion of world catastrophe. Is this classic symptom still relevant today?, 730 - 738

Short report

2015/2 themanummer Bewegingsstoornissen

S. van den Ameele, B. Sabbe, M. Morrens

Characteristics of catatonia in schizophrenia and mood disorders, 94 - 98

Short report

2015/2 themanummer Bewegingsstoornissen

L. Docx, B.G.C. Sabbe, J. Koning, T.Q. Mentzel, P.N. van Harten, M. Morrens

Instrumental registration of psychomotor symptoms in schizophrenia: has the time come to use the technique in clinical practice?, 148 - 153

Short report

2015/2 themanummer Bewegingsstoornissen

D.E. Tenback, P.R. Bakker, P.N. van Harten

Risk factors for tardive movement disorders in schizophrenia, 120 - 124

Review article


J. Van Hecke, T.E. Gladwin, J. Coremans, W. Hulstijn, B. Sabbe

Functional MRI for schizophrenia: importance of the type of task being scanned, 385 - 393